Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Clinical Oncology
How can oncologists successfully implement precision medicine strategies in diffuse large B-cell lymphoma (DLBCL)? In this review, the authors describe the recently proposed genomic categories of DLBCL and their potential use for personalized treatment, as well as the significant challenges they will present.
Hematology August 31st 2020